Bronchial Thermoplasty provides long-term asthma control

August 28, 2019

Bronchial Thermoplasty (BT) is a non-pharmacologic treatment for asthma that has been shown to result in significant improvements in a number of asthma control measures in three randomized clinical trials in patients with moderate-to-severe, persistent asthma. The Asthma Intervention Research 2 (AIR2) Trial, a double-blind, sham-controlled, randomized clinical trial of BT in patients with severe asthma, showed a 32% reduction in severe exacerbations, an 84% reduction in emergency room (ER) visits due to respiratory symptoms, and a 66% reduction in time lost from work/school/other daily activities due to asthma symptoms compared to a sham-treated group in the first year following the BT treatment period (day of first BT procedure until 6 weeks after the last bronchoscopy, approximately 12 weeks).

Need help?

Leave your contact details and we will be happy to answer all your questions.

By clicking the «Send» button, you agree for the processing of personal data